pemafibrate
kowa pharmaceuticals
['pemafibrate', 'cardio', 'prominent']
another fibrate fails to show cardiovascular benefit
in the prominent trial, pemafibrate did not reduce incidence of the composite cardiovascular endpoint. #aha22 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.